Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2000
03/07/2000US6034230 Modulate inflammatory heart disease.
03/07/2000US6034127 Amidino protease inhibitors
03/07/2000US6034123 Method for altering blood lipid levels
03/07/2000US6034115 Indolyl-substituted phenylacetic acid derivatives
03/07/2000US6034113 Derivatives of 1,3,4-oxadiazolone
03/07/2000US6034109 Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia
03/07/2000US6034102 Atherosclerosis treatment
03/07/2000US6034098 Inhibitors of microsomal triglyceride transfer protein and method
03/07/2000US6034094 Pharmaceutically useful 3,4-dihydroisoquinoline
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034053 Vascular disorders
03/07/2000US6033910 Antisense inhibition of MAP kinase kinase 6 expression
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000CA2195093C Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
03/02/2000WO2000011478A1 Assays, methods and means for modulating nuclear localisation
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011014A1 49 human secreted proteins
03/02/2000WO2000011010A1 Phosphoglycolipid and methods for its use
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010980A1 Pyrimidinone derivatives for the treatment of atherosclerosis
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000WO2000010601A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
03/02/2000WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity
03/02/2000WO2000010536A1 Extended release buccal bioadhesive tablet
03/02/2000WO2000010529A1 Oral liquid mucoadhesive compositions
03/02/2000WO1999064409A3 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999057146A9 Protein mixtures to induce therapeutic angiogenesis
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1998051662A3 Compounds and methods for the inhibition of the expression of vcam-1
03/02/2000DE19839499A1 2-Oxo-2H-chinolinderivate 2-oxo-2H-quinoline
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000DE19838705A1 Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one New dihydro- (1,2,3) triazolo [4,5-d] pyrimidin-7-one
03/02/2000DE19838636A1 Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein A carotenoid formulation comprising a mixture of beta-carotene, lycopene and lutein
03/02/2000DE19816894C1 SREBP-2-defiziente Zellinien SREBP-2-deficient cell lines
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341586A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341357A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2340884A1 49 human secreted proteins
03/02/2000CA2340649A1 Phosphoglycolipid and methods for its use
03/02/2000CA2340466A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339537A1 Regulation of substrate activity
03/02/2000CA2338837A1 Assays, methods and means for modulating nuclear localisation
03/01/2000EP0982400A1 Human glycine transporter
03/01/2000EP0982305A1 Indane-1-ol derivatives, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
03/01/2000EP0981969A1 Carotinoid compositions comprising a mixture of beta-carotene, lycopene and lutein
03/01/2000EP0981526A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0981374A2 Sustained-release delayed gels
03/01/2000EP0981352A1 Aplidine as an l-type calcium channel enhancer
03/01/2000EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
03/01/2000EP0981339A1 Use of a pharmaceutical composition for treating and/or preventing ischemia
03/01/2000EP0981337A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
03/01/2000EP0861070B1 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis
03/01/2000EP0673374B1 Pharmaceutical composition containing bicyclic type compounds
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246154A OB fusion protein compositions and methods
03/01/2000CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments
03/01/2000CN1246117A 1,2-dihydroindene or indoline derivatives
03/01/2000CN1246110A Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same
03/01/2000CN1245803A Method for preparing substituted pyridines
03/01/2000CN1245715A Yankang powder (paste) for relieving inflammation
03/01/2000CN1049888C Process for preparing benzoylguanidine
03/01/2000CA2246791A1 Treatment of endothelium with somatostatin analogues
02/2000
02/29/2000US6030999 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
02/29/2000US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse;
02/29/2000US6030943 Dehydrodidemnin B as an L-type calcium channel enhancer
02/29/2000US6030831 Tie ligand homologues
02/29/2000US6030621 Ginkgo biloba composition, method to prepare the same and uses thereof
02/29/2000CA2280049A1 Diarylsulfonylurea binding proteins
02/29/2000CA2199613C Indole-2,3-dione-3-oxime derivatives, their preparation and use
02/29/2000CA2169179C 5-arylindole derivatives
02/28/2000CA2249037A1 Novel compounds
02/24/2000WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
02/24/2000WO2000009692A1 Novel peptides capable of modulating inflammatory heart disease
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009688A1 Novel gene and protein osbh encoded thereby
02/24/2000WO2000009675A1 Adenovirus formulations for gene therapy
02/24/2000WO2000009672A1 Dnazymes and methods for treating restenosis
02/24/2000WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory
02/24/2000WO2000009542A1 SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES
02/24/2000WO2000009537A2 Compounds having growth hormone releasing activity
02/24/2000WO2000009512A2 Bipyridine manganese complexes
02/24/2000WO2000009510A1 Photocyclized rapamycins
02/24/2000WO2000009507A1 Phenyl yanthine derivatives
02/24/2000WO2000009503A1 Integrin receptor antagonists
02/24/2000WO2000009496A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
1 ... 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 ... 1595